Anne Altmeyer Sells Corbus Pharmaceuticals Holdings Inc. Shares

Summary

Anne Altmeyer, a board member of Corbus Pharmaceuticals Holdings (NASDAQ: CRBP), sold 1,392 shares at an average price of $7.25, totaling $10,092.00, reducing her holdings by 50.02%. After the transaction, she holds 1,391 shares valued at approximately $10,084.75. Year-to-date, the stock has risen 342%, but it recently fell by 1.1%. Analysts’ opinions on the stock are mixed, with a common target price of $50.88. Institutional investors have increased their holdings, with 64.64% of the stock held by hedge funds and other institutions.Market Beat

Impact Analysis

This is a company-level event as it pertains to insider trading within Corbus Pharmaceuticals Holdings. The sale of shares by Anne Altmeyer might signal her personal assessment of the stock’s current valuation or future prospects, possibly affecting investor sentiment negatively in the short term. Despite her sale, the stock has performed strongly this year with a significant increase of 342% year-to-date, although it recently experienced a slight decline of 1.1%. Analysts have varied opinions on the stock, indicating uncertainty or differing expectations about the company’s future performance, which is reflected in their mixed ratings and the target price of $50.88. The fact that institutional investors have increased their holdings suggests confidence in the company’s long-term potential. Investors should consider the recent insider sale alongside the strong institutional backing and analyst target price when evaluating investment opportunities or risks.Market Beat